Since an immunoassay technique was first applied for measurement of glucagon, many studies on circulating glucagon levels under various conditions have been conducted. Their results, however, are not necessarily unanimous, as suggested by the fact that more than twenty fold differences in plasma immunoreactive glucagon (IRG) values in fasting healthy subjects have been reported. (Schalch, 1966; Aguilar-Parada et al., 1969) Several factors are considered to be responsible for the wide range of reported plasma IRG concentrations in the basal condition. One possible factor may be connected with the problem of the concomitant presence in plasma of an IRG of extrapancreatic as well as pancreatic origin, as suggested in the studies of Samols et al.(1966) and Valverde et al. (1967, 1970 a and b) . Plasma IRG levels of normal subjects reported by Aguilar-Parada et al.(1969) , using an antiglucagon serum which reacted poorly with gut glucagon, were notably lower than those determined with antisera which might crossreact to a moderate degree with gut glucagon. These facts show that an unequal affinity of antiglucagon sera employed by various investigators for endogenous gut and pancreatic glucagon might be one of the causes for the striking differences in normal plasma IRG levels.
The present study was undertaken to throw light on this problem by using two different antiglucagon sera which reacted with gut glucagon to varying degrees.
Materials and Methods
Antiserum to glucagon was prepared in rabbits using a modification of the method of Assan et al. (1965) patient before and after oral glucose using both antisera. Here again, similar findings to those in Table 2 , were observed. The dilution curve for IRG in the plasma sample obtained from the pancreatectomized patient was shallower than that for pancreatic glucagon, but superimposed on the curve for IRG in the gut extract shown in Figure 3 , indicating that IRG contained in the samples from the patient was derived exclusively from gut glucagon. The recoveries of pancreatic glucagon added to plasma from the pancreatectomized patient were found to be satisfactory, ranging from 90 to 100%, irrespective of the antisera employed (Table 3) . On the other hand, there were difference between the recoveries of gut glucagon added to plasma, when measured with #150 and #159, and the values measured with #159 were higher than those with
Discussion
The difficulties in the specific measurement of pancreatic glucagon in plasma by radioim- Table 3 . Recovery of pancreatic glucagon added to plasma of a pancreatectomized subject Table 4 . Recovery of human gut extract added to plasma munoassay have handicapped research on circulating glucagon levels, resulting in widely divergent findings of plasma glucagon levels by different authors, (Unger et al., 1963; Samols et al., 1965; Schalch, 1966; Lawrence, 1966; Shima and Foa, 1968; Vance et al., 1968; Aguilar-Parade et al., 1969) , and have contributed to a confusion of understanding of the physiological role of this material.
The presence of gut glucagon in plasma is now an established fact (Buchanan et al., 1967; Unger et al., 1968) . Since pancreatic and gut glucagon have shown appreciable amounts of immunoreactivity by the glucagon immunoassay using ordinary glucagon antiserum (Heding, 1971) , the total immunoreactivity on this assay procedure is composed of both immunoreactive pancreatic glucagon and immunoreactive gut glucagon. Therefore, when pancreatic glucagon was adopted as a standard for the assay of gut glucagon and the results were described in the amount of pancreatic glucagon equivalency, variable results would be inevitably found, depending on the difference in crossreactivity of the antiserum with pancreatic glucagon and with gut glucagon.
Two antisera, #150 and #159, employed in the present study gave identical dilution curves for pancreatic glucagon, but different ones for gut glucagon, indicating the varying degrees of their affinity for gut glucagon (Fig.1) . If the contents of IRG in a certain weight of the gut extract are measured with these antisera using pancreatic glucagon as a standard, the values obtained with # 150 must be different from those with # 159. The results in Table 1 show that this is the case. Furthermore, the fact that the content of IRG in the same plasma sample measured with #159 was higher than that with # 150 when expressed in terms of pancreatic glucagon, might be attributed to the concomitant presence in plasma of gut glucagon of which the reading was higher when assayed with the results of the recoveries of pancreatic and gut glucagon added to the plasma samples.
Although the present study has revealed one of the factors which may invalidate the radioimmunological determination of glucagon in plasma, more work is needed on this assay in order to clarify other problems such as reactivity of the pancreatic glucagonspecific antiserum with degraded fragments of glucagon (Heding, 1971) .
